Regulatory Relief

The regulatory burden faced by hospitals is substantial and unsustainable.

Every day, hospitals, health systems and post-acute care providers confront the daunting task of complying with a growing number of federal regulations. They are constantly challenged to understand and implement new or revised regulations, while maintaining their core mission of providing high-quality patient care.

Providers appreciate that federal regulation is intended to ensure that health care patients receive safe, high-quality care, and prioritize it as a critical part of their day-to-day work.

But the scope and pace of the changes being made is out-stripping many providers’ ability to absorb them. At the same time, many of these regulations do not improve the quality of patient care or access to services.

Providers need relief now. Read on for more information and resources on the AHA's regulatory relief agenda.

Jan 18, 2018
AHA President and CEO Rick Pollack yesterday hosted Centers for Medicare & Medicaid Services Administrator Seema Verma on a special AHA Town Hall webcast focused on the current regulatory landscape and efforts that the agency is considering that could provide regulatory relief to hospitals and…
Jan 18, 2018
Infographic: Regulatory Burden Overwhelming Providers, Diverting Clinicians from Patient Care (PDF)
Jan 17, 2018
New industry effort will help simplify processes and improve communications for more efficient patient care
  WASHINGTON – January 17, 2018 – Physicians, pharmacists, medical groups, hospitals, and health insurance providers are working together to improve prior authorization processes for patients’ medical treatments, also known as pre-approval. This will help patients have access to safe,…
Dec 7, 2017
AHA again urged the Food and Drug Administration today to allow health system pharmacies to distribute compounded products to other system facilities located more than one mile away. “The AHA is concerned that the one-mile radius limitation [included in draft guidance last year] is not workable for…
Dec 7, 2017
AHA again urged the Food and Drug Administration today to allow health system pharmacies to distribute compounded products to other system facilities located more than one mile away. “The AHA is concerned that the one-mile radius limitation [included in draft guidance last year] is not workable for…
Dec 7, 2017
The Food and Drug Administration today released for comment draft guidance clarifying what types of clinical and patient decision support software would no longer be regulated by the agency as a medical device under the 21st Century Cures Act. FDA Commissioner Scott Gottlieb, M.D., said the…
Dec 7, 2017
AHA responds to the Food and Drug Administrations request for information on regulatory flexibilities and efficiencies.
Nov 13, 2017
The AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals today filed a federal lawsuit to prevent the Centers for Medicare…
Nov 3, 2017
Assessing the Regulatory Burden on Health Systems, Hospitals and Post-acute Care Providers
Every day, health systems, hospitals and post-acute care (PAC) providers – such as long-term care hospitals, inpatient rehabilitation facilities, skilled nursing facilities and home health agencies – confront the daunting task of complying with a growing number of federal regulations. Federal…